Ebrotidine (FI3542) is a competitive histamine H2-receptor antagonist with a Ki of 127.5 nM. It exhibits potent gastric antisecretory and gastroprotective effects, making it a useful research tool for studying peptic ulcer disease and gastric acid secretion in both in vitro and in vivo experimental models.
